AI & Emerging Technology

A new patent for its lead cancer drug in Japan is more than a legal win; it's a strategic move to secure a future market into the 2040s.

Broadway star Morgan Dudley returns to the tech platform that discovered her. Can her insider role help Stargaze win the high-stakes talent-tech race?

Imviva Biotech's 'off-the-shelf' cell therapies could make life-saving treatments faster and more accessible. But what does this mean for patients?

With its finances in distress, Netcapital bets its future on blockchain and a new CEO. Can a turnaround specialist navigate the crypto frontier?

A massive natural gas pipeline aims to fuel Nevada's tech boom. But does this $1.7 billion bet on fossil fuels conflict with the state's green energy future?

Drone Nerds' new partnership with Creality is more than a product expansion. It's a strategic move by parent XTI Aerospace into digital fabrication.

A new 31-strain vaccine enters final trials, threatening to upend the market and offer unprecedented protection against a persistent bacterial threat.

Sensorion clears a key safety hurdle for its infant hearing loss gene therapy, but early data reveals a tight race to market against formidable rivals.

A routine filing from a quant fund reveals subtle shifts in the high-stakes merger of American Axle and Dowlais. What does it mean for the bottom line?

In a complex financial market, one firm's new L&D chief isn't just a hire; it's a strategic weapon. Here's why their investment in talent could pay dividends.

The off-price giant is ditching traditional ads for a superfan bus tour. We analyze why this experiential move signals a major shift in retail marketing.

Andersen Consulting partners with Romanian software firm Codezilla. We decode the strategy, the nearshoring trend, and what it means for the competition.

Lion Group is diversifying its crypto-heavy treasury with Bitcoin. Is this a savvy move in a cool market or a high-stakes bet for a volatile company?